跳至主要内容
临床试验/JPRN-UMIN000010309
JPRN-UMIN000010309已完成未知

The effect of enoxaparin with cilostazol for prevention of venous thromboembolism after total knee and hip arthroplasty - The effect of cilostazol for prevention of venous thromboembolism after arthroplasty

Department of orthopedic surgery, Tokyo women's medical university0 个研究点目标入组 50 人开始时间: 2013年3月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • We exclude patients with active bleeding or a high risk of bleeding that contraindicated the use of low-molecular-weight heparin and patients with any contraindication to the use of enoxaparin or cilostazol. Other exclusion criteria include conditions clinically significant compromised renal function, acute endocarditis, heparin induced thrombocytopenia, congestive heart failure, and pregnancy or breast-feeding.

研究者

发起方
Department of orthopedic surgery, Tokyo women's medical university

相似试验